These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4552286)

  • 1. Acute changes in serum calcium after renal transplantation.
    Silber SJ; Konnak J; McDonald FD
    J Urol; 1972 Apr; 107(4):533-7. PubMed ID: 4552286
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal osteodystrophy.
    Beale MG; Salcedo JR; Ellis D; Rao DD
    Pediatr Clin North Am; 1976 Nov; 23(4):873-84. PubMed ID: 186748
    [No Abstract]   [Full Text] [Related]  

  • 3. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium metabolism and kidney disease.
    Binswanger U
    Ergeb Inn Med Kinderheilkd; 1974; 34(0):105-53. PubMed ID: 4608434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Disorders of calcium phosphate homeostasis in patients with intermittent hemodialysis therapy].
    Pogglitsch H; Holzer H; Giessauf W; Stöckl G
    Wien Med Wochenschr; 1972 May; 122(22):311-7. PubMed ID: 5045838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of uremic osteodystrophy].
    Fletti C; Docci D; Coli' L; Di Felice A
    G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295
    [No Abstract]   [Full Text] [Related]  

  • 7. Parathyroidectomy for the treatment of renal osteodystrophy and tertiary hyperparathyroidism: progress report.
    Popowniak KL; Esselstyn CB; Nakamoto S
    Surg Clin North Am; 1974 Apr; 54(2):325-38. PubMed ID: 4593909
    [No Abstract]   [Full Text] [Related]  

  • 8. Some biochemical, histological, radiological and clinical features of renal osteodystrophy.
    Eastwood JB; Bordier PJ; de Wardener HE
    Kidney Int; 1973 Aug; 4(2):128-40. PubMed ID: 4583084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of renal osteodystrophy: physiopathology and secondary effects].
    Haldimann B; Flury W
    Schweiz Med Wochenschr; 1977 Aug; 107(32):1113-8. PubMed ID: 333572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis.
    Meyrier A; Marsac J; Richet G
    Kidney Int; 1973 Aug; 4(2):146-53. PubMed ID: 4744972
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis, etiology and treatment of renal osteopathy].
    Raszeja-Wanic B; Kontek M
    Pol Tyg Lek; 1972 Sep; 27(37):1457-9. PubMed ID: 4344405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic renal insufficiency and calcium].
    Ogura Y; Sakai S; Kawaguchi Y; Yamamoto M; Kimura Y
    Nihon Rinsho; 1974 Mar; 32(3):463-70. PubMed ID: 4603390
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal osteodystrophy in children: progress in its management.
    Chan JC
    Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on renal osteodystrophy: pathogenesis and clinical management.
    Sakhaee K; Gonzalez GB
    Am J Med Sci; 1999 Apr; 317(4):251-60. PubMed ID: 10210362
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E; Craver L
    Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract]   [Full Text] [Related]  

  • 17. A calcium kinetic approach to the problem of renal osteodystrophy.
    Gonick HC; Drinkard JP; Hertoghe J; Rubini ME
    Clin Orthop Relat Res; 1974 May; (100):315-36. PubMed ID: 4838415
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
    Verberckmoes R; Bouillon R; Krempien B
    Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural course of secondary hyperparathyroidism after successful renal transplantation.
    Roof BS; Piel CF; Carpenter BJ; Gordan GS; Kountz S; Belzer F
    Proc Clin Dial Transplant Forum; 1971; 1():11-20. PubMed ID: 4951041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hydroxyproline in the dialysate as a parameter of secondary hyperparathyroidism. Effects of phosphate reduction and alkalization].
    Schiessl JH; Schweigart U; Bottermann P; Kopp KF
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1310-3. PubMed ID: 25525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.